AMPD2 Gene Pontocerebellar hypoplasia, type 9 NGS Genetic Test
Short Name: AMPD2 NGS Genetic Test
Also known as: AMPD2 Gene NGS Test, Pontocerebellar Hypoplasia Type 9 Genetic Test
AMPD2 Gene Pontocerebellar hypoplasia, type 9 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are issued within 3 to 4 weeks of sample receipt. You will receive an email or WhatsApp notification when the report is ready.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last reviewed: September 7, 2026
Overview
The purpose of this NGS genetic test is to identify pathogenic variants in the AMPD2 gene that are associated with Pontocerebellar Hypoplasia, Type 9. It also assists in confirmatory diagnosis, carrier identification, genetic counselling, and family risk assessment.
- Test Code
- 4482
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are issued within 3 to 4 weeks of sample receipt. You will receive an email or WhatsApp notification when the report is ready.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Sample Collection
No fasting is required. Patients are advised to bring previous neurological assessment records and family history documents. A genetic counselling session is an important component of the pre-test process.
Method: Blood withdrawal or dried blood spot on FTA card
Laboratory Analysis
A qualified phlebotomist will collect a small volume of blood using a sterile EDTA tube. In the case of an FTA card, one drop of blood is applied to each indicated circle and allowed to air-dry.
Report Delivery
The patient can resume daily activities immediately. The collected sample will be transported to the laboratory for DNA extraction and NGS analysis.
Timeline: Reports are issued within 3 to 4 weeks of sample receipt. You will receive an email or WhatsApp notification when the report is ready.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this NGS genetic test is to identify pathogenic variants in the AMPD2 gene that are associated with Pontocerebellar Hypoplasia, Type 9. It also assists in confirmatory diagnosis, carrier identification, genetic counselling, and family risk assessment.
How to Prepare
- No fasting required.
- Use the EDTA blood collection tube provided by DNA Labs India.
- Ensure the FTA blood spot is completely dry before placing it in the transport bag.
- Clearly label the sample with the patient's full name, date of birth, and sample collection date.
- Please forward the filled test request form and laboratory requisition slip along with the sample.
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"Genetic results must be interpreted in the context of clinical symptoms, family history, and a documented pedigree. I recommend a post-test genetic counselling session to explain the implications for the patient and family members."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Grossly haemolysed or clotted EDTA sample
- Insufficient sample quantity
- FTA card with contaminated or overlapping blood spots
- Missing patient identifiers or signed consent
- Sample received in a leaking or broken container
Understanding Your Results
No pathogenic variant detected
Reduces the likelihood of AMPD2-related Pontocerebellar Hypoplasia Type 9; however, the disorder cannot be completely excluded if clinical suspicion is high.
Pathogenic or likely pathogenic variant detected
Supports a molecular diagnosis of AMPD2-related disease when consistent with clinical features. Genetic counselling is recommended.
Variant of uncertain significance (VUS)
The clinical impact is currently unclear. Additional family segregation studies may help determine whether the variant is disease-causing.
If the result is positive, uncertain, or if the patient continues to have progressive neurological symptoms, please consult a neurologist and a clinical geneticist for comprehensive management, further testing, and family counselling.
Limitations
- ⚠This is a targeted single-gene test and will not detect mutations in other genes involved in pontocerebellar hypoplasia.
- ⚠NGS may not detect all mutation types, such as large deletions, deep intronic variants, or trinucleotide repeat expansions.
- ⚠A variant of uncertain significance (VUS) may be reported; additional family testing may be needed to classify the variant.
Risks & Considerations
- ●Minimal bleeding at the puncture site
- ●Small chance of bruising
- ●Very low risk of infection
Interfering Factors
- ●Inadequate DNA concentration or degraded DNA
- ●Contamination of sample during collection
- ●FTA card not dried completely before packing
- ●Improper sample labelling or patient identification
- ●Clinical misclassification or unavailable family history
Compare With Similar Tests
| Test | AMPD2 Gene Pontocerebellar hypoplasia, type 9 NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | AMPD2 Gene Pontocerebellar hypoplasia, type 9 NGS Genetic Test |
Frequently Asked Questions
What is the cost of the AMPD2 gene PCH type 9 NGS genetic test?
What type of sample is required for this test?
Do I need to fast before the AMPD2 NGS test?
How long will the results take?
What technology is used for AMPD2 gene analysis?
Which symptoms are associated with Pontocerebellar Hypoplasia Type 9?
Can this test identify carriers of AMPD2 mutations?
Is genetic counselling included in the test process?
What does a positive AMPD2 test result mean?
Will this test cover other genes related to pontocerebellar hypoplasia?
Is home sample collection available for this test?
What should I do before giving the sample?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
